Article Text

PDF

GW23-e1192
EFFECTS OF ATORVASTATIN ON METHYLATION AND MRNA EXPRESSION OF BCL-2 IN HYPERLIPIDAEMIA WISTAR RATS
  1. Wang Yiyong,
  2. Jia Shaobin
  1. Center of Cardiology, General Hospital, Ningxia Medical University

    Abstract

    Objectives To investigate effects of atorvastatin on methylation status of bcl-2 gene promoter and mRNA expression of bcl-2 in aortic tissue of hyperlipidaemia Wistar rats.

    Methods 66 Wistar rats were equally randomised into three groups: control group, hyperlipidaemia group and hyperlipoidaemia rat with atorvastatin group. The rats in control group were fed a normal chaw, and the other groups were fed a chaw formula as designed for 12 weeks. From the 12th week gavage experiment, after 4 weeks of heart blood was then drawn for detection of serum cholesterol, triglyceride, low density lipoprotein-cholesterol, high density lipoprotein-cholesterol; aortic nucleoprotein was extracted for detection of DNA methyltransferase activity. The methylation specific polymerase chain reaction (MSP) method was used to detect bcl-2 gene methylation in aortic tissue of control group, hyperlipidemia group and hyperlipoidemia rat with atorvastatin group. The expression of bcl-2 mRNA in aortic tissue of control group and hyperlipidaemia group Wistar rats was detected by real-time quantitative polymerase chain reaction.

    Results A high-fat diet for 12 weeks is sufficient to induce hyperlipidaemia; Atorvastatin supplementation to the rats fed the high-fat diet prevented an elevation total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol (LDL-C) and increase high density lipoprotein-cholesterol (HDL-C) levels in the serum (p<0.05) and morphological changes in the thoracic aorta. Compared with the control group, hyperlipidaemia group significantly increased DNA methyltransferase activity and methylation status of bcl-2 gene promoter (p<0.05), the expression of bcl-2 mRNA was decreased in hyperlipidaemia groups (p<0.05). Compared with the hyperlipidaemia group, atorvastatin group significantly decreased DNA methyltransferase activity and methylation status of bcl-2 gene promoter (p<0.05), the expression of bcl-2 mRNA was increased in hyperlipidaemia groups (p<0.05).

    Conclusions Atorvastatin supplementation can blunt the rise in methylation status of bcl-2 gene promoter but also can increase the expression of bcl-2 mRNA in the aorta of rats with hyperlipidaemia. The study provide new ideas for prevention and delay of atherosclerosis.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.